Abualassal_2016_Biomed.Chromatogr_30_1416

Reference

Title : Regioselective deprotection of the monosaccharide-bearing thiocyanomethyl group at the anomeric position monitored by reversed-phase HPLC method - Abualassal_2016_Biomed.Chromatogr_30_1416
Author(s) : Abualassal Q , Al Azzam KM , Jilani JA
Ref : Biomedical Chromatography , 30 :1416 , 2016
Abstract :

In the current work, the investigation and development of a chemo-enzymatic approach for the synthesis of neo-glycoproteins have been studied. This strategy is based on the regioselective enzymatic hydrolysis of peracetylated monosaccharide, functionalized at the anomeric position (C1) as 1-thio-(S-cyanomethyl) group, a precursor of the 2- iminomethoxyethyl thioglycosides-linker for protein glycosylation, catalyzed by immobilized enzymes to obtain selectively monodeprotected compounds. The use of this activation in C1 is the most frequently used strategy for glycoprotein preparation. The selected biocatalysts are the lipase from Candida rugosa and the acetyl xylan esterase from Bacillus pumilus. A reversed-phase high-performance liquid-chromatographic (HPLC) method for monitoring the regioselective deprotection reaction has been developed. The developed HPLC method was used as a fingerprint to follow the hydrolysis of substrate 1 to substrate 1a and to determine its purity and yield. Moreover, the obtained compound was further purified by flash chromatography. The obtained compound 1a was further characterized using (1) H, (13) C NMR, correlation spectroscopy (COSY) and heteronuclear multiple bond correlation. The resulting product can be used as an intermediate for the preparation of di- and more complex oligosaccharides aimed at protein conjugation. Copyright (c) 2016 John Wiley & Sons, Ltd.

PubMedSearch : Abualassal_2016_Biomed.Chromatogr_30_1416
PubMedID: 26864255

Related information

Citations formats

Abualassal Q, Al Azzam KM, Jilani JA (2016)
Regioselective deprotection of the monosaccharide-bearing thiocyanomethyl group at the anomeric position monitored by reversed-phase HPLC method
Biomedical Chromatography 30 :1416

Abualassal Q, Al Azzam KM, Jilani JA (2016)
Biomedical Chromatography 30 :1416